Attached files

file filename
8-K/A - 8-K/A - CYPRESS SEMICONDUCTOR CORP /DE/amendmenttothe8-kfiled.htm
EX-23.1 - EXHIBIT 23.1 - CYPRESS SEMICONDUCTOR CORP /DE/ex231.htm
EX-99.1 - EXHIBIT 99.1 - CYPRESS SEMICONDUCTOR CORP /DE/exhibit991_03122015.htm
EXHIBIT 99-2
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS
On March 12, 2015, Cypress Semiconductor Corporation ("Cypress") completed its previously announced merger of Spansion Inc. ("Spansion") purport to the Agreement and Plan of Merger and Reorganization, as of December 1, 2014 (the "merger agreement"), by and among Cypress, Spansion and the other parties named therein (the "merger").
The unaudited pro forma condensed combined balance sheet as of December 28, 2014 is presented as if the merger had occurred as of December 28, 2014. The unaudited pro forma combined condensed statements of operations for the year ended December 28, 2014 is presented as if the merger had occurred on December 30, 2013. In addition, the pro forma consolidated financial statements of Cypress and Spansion have been adjusted to reflect certain reclassifications in order to conform to Cypress’s financial statement presentation and the presentation of the combined company.
The unaudited pro forma condensed combined financial statements gives effect to the merger under the acquisition method of accounting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standard Topic 805, Business Combinations (“ASC 805”), with Cypress treated as the acquirer. The value of the consideration paid by Cypress upon the consummation of the merger is determined based on the closing price per share of Cypress’s common stock on March 12, 2015. As of the date of the filing of this Form 8-K/A, Cypress has not completed the detailed valuation work necessary to arrive at the required estimates of the fair value of the Spansion assets acquired and the liabilities assumed and the related allocation of purchase price, nor has it identified all adjustments necessary to conform Spansion’s accounting policies to Cypress’s accounting policies. Therefore, Cypress has not finalized the purchase price allocation for this merger. As a result of the foregoing, the pro forma adjustments are preliminary and are subject to change as additional information becomes available and as additional analysis are performed. The preliminary pro forma adjustments have been made solely for the purpose of presenting the unaudited pro forma condensed combined financial statements. Cypress estimated the fair value of Spansion’s assets and liabilities as of December 28, 2014 based upon on a preliminary valuation and due diligence. Final valuations will be performed based on the actual net tangible and intangible assets of Spansion as of the date of the merger. The final purchase price allocation may be different than that reflected in the pro forma purchase price allocation presented herein, and this difference may be material.
Assumptions and estimates underlying the unaudited adjustments to the pro forma condensed combined financial statements are described in the accompanying notes, which should be read in conjunction with the unaudited pro forma condensed combined financial statements. The historical consolidated financial statements have been adjusted in the unaudited pro forma condensed combined financial statements to give effect to pro forma events that are: (1) directly attributable to the merger; (2) factually supportable; and (3) with respect to the unaudited pro forma condensed combined statements of operations, expected to have a continuing impact on the combined results of Cypress and Spansion following the merger.  
In connection with the plan to integrate the operations of Cypress and Spansion, Cypress anticipates that non-recurring charges, such as costs associated with systems implementation, relocation expenses, severance, compensation charges under change of control agreements with certain employees and other costs related to exit or disposal activities, will be incurred. Cypress is not able to determine the timing, nature and amount of these charges as of the date of the filing of this Form 8-K/A. However, these charges could affect the combined results of operations of the combined company following the merger, in the period in which they are recorded. The unaudited pro forma condensed combined financial statements do not include the effects of the costs associated with any restructuring or integration activities resulting from the transaction, as they are non-recurring in nature and not factually supportable at the time that the unaudited pro forma condensed combined financial statements were prepared. Additionally, these adjustments do not give effect to any synergies that may be realized as a result of the merger, nor do they give effect to any nonrecurring or unusual restructuring charges that may be incurred as a result of the integration of the two companies.
The unaudited pro forma condensed combined financial statements do not purport to project the future combined operating results or financial position of Cypress and Spansion following the merger and acquisition. The unaudited pro forma condensed combined financial statements should be read in conjunction with the historical financial statements and accompanying notes of Spansion, which are included in Exhibit 99.1 of this Form 8-K/A.






 
Unaudited Pro Forma Condensed Combined Balance Sheet of Cypress Semiconductor Corporation and Spansion Inc.
 
(in thousands, except par value and share amounts)
 
 
 
 
 
 
 
 
 
 
 
Historical
 
 
 
 
 
 ASSETS
  Cypress Semiconductor Corporation
December 28, 2014
 
Spansion Inc.
December 28, 2014
 
Pro Forma Adjustments (Note 4)
Footnote
Pro Forma Combined
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
103,736

 
$
250,065

 
$
(193,037
)
(a), (b)
$
160,764

 
Short-term investments
15,076

 
50,588

 

 
65,664

 
Accounts receivable, net
75,984

 
136,863

 

 
212,847

 
Inventories
88,227

 
310,724

 
88,867

 (c)
487,818

 
Other current assets
29,288

 
70,269

 

 
99,557

 
     Total current assets
312,311

 
818,509

 
(104,170
)
 
1,026,650

 
Property, plant and equipment, net
237,763

 
199,395

 
243,557

 (d)
680,715

 
Goodwill
65,696

 
166,133

 
1,385,039

(e)
1,616,868

 
Intangible assets, net
33,918

 
131,529

 
682,941

(f)
848,388

 
Other long-term assets
93,593

 
59,606

 
335

(k)
153,534

 
     Total assets
$
743,281

 
$
1,375,172

 
$
2,207,702

 
$
4,326,155

 
 
 
 
 
 
 
 
  
 
LIABILITIES AND EQUITY
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
Accounts payable
$
42,678

 
$
173,698

 
$

 
$
216,376

 
Accrued compensation and employee benefits
35,182

 
34,079

 

 
69,261

 
Deferred margin on sales to distributors
95,187

 
35,283

 
(35,283
)
(j)
95,187

 
Dividends payable
17,931

 

 

 
17,931

 
Income taxes payable
2,710

 
1,361

 

 
4,071

 
Current portion of long-term debt
6,143

 
37,881

 
(37,881
)
(b)
6,143

 
Other current liabilities
75,001

 
145,143

 
61,230

 (g)
281,374

 
     Total current liabilities
274,832

 
427,445

 
(11,934
)
 
690,343

 
Deferred income taxes and other tax liabilities
18,784

 
24,252

 

 
43,036

 
Long-term revolving credit facility and debt, non current
237,107

 
372,296

 
(137,259
)
(b), (h), (i)
472,144

 
 
Other long-term liabilities
10,693

 
22,495

 

 
33,188

 
     Total liabilities
541,416

 
846,488

 
(149,193
)
 
1,238,711

 
 
 
 
 
 
 
 
 
 
Commitments and contingencies

 

 

 

 
Equity:
 
 
 
 
 
 
 
 
 Preferred stock

 

 

 

 
 Common stock
3,039

 
63

 
1,639,260

 (h)
1,642,362

 
Additional paid-in capital
2,675,170

 
806,916

 
467,251

 (a), (b),(i), (h)
3,949,337

 
Accumulated other comprehensive loss
(46
)
 
(275,993
)
 
275,993

 (h)
(46
)
 
Accumulated deficit
(379,913
)
 
(2,302
)
 
(25,609
)
 (h), (g)
(407,824
)
 
Stockholders equity before treasury stock
2,298,250

 
528,684

 
2,356,895

 
5,183,829

 
Less: shares of common stock held in treasury, at cost; 143,158
(2,090,493
)
 

 

 
(2,090,493
)
 
     Total stockholders' equity
207,757

 
528,684

 
2,356,895

 
3,093,336

 
Noncontrolling interests
(5,892
)
 

 

 
(5,892
)
 
     Total equity
201,865

 
528,684

 
2,356,895

 
3,087,444

 
     Total liabilities and equity
$
743,281

 
$
1,375,172

 
$
2,207,702

 
$
4,326,155

 
 
 
 
 
 
 
 
 
 
The accompanying notes are an integral part of these condensed consolidated financial statements




Unaudited Pro Forma Condensed Combined Consolidated Statement of Operations of Cypress Semiconductor Corporation and Spansion Inc.
 
Historical
 
 
 
 
 
 
 
  Cypress Semiconductor Corporation
For the Year Ended December 28, 2014
 
Spansion Inc.
For the Year Ended December 28, 2014
 
Pro Forma Adjustments (Note 4)
 
Footnote
 
Pro Forma Combined
 
(in thousands, except par value and share amounts)
 
 
 
 
 
 
 
 
 
 
Revenues
$
725,497

 
$
1,251,855

 
$

 
 
 
$
1,977,352

Cost and expenses:
 
 
 
 
 
 
 
 
 
   Cost of revenues
361,820

 
833,601

 
117,088

 
 (B)
 
1,312,510

   Research and development
164,560

 
171,203

 
(4,374
)
 
 (B)
 
331,388

   Selling, general and administrative
170,741

 
249,346

 
(13,332
)
 
 (B)
 
406,755

   Amortization of acquisition-related intangible assets
6,683

 
35,974

 
101,069

 
 (A)
 
143,726

   Restructuring costs
(1,180
)
 

 

 
 
 
(1,180
)
          Total costs and expenses
702,624

 
1,290,124

 
200,451

 
 
 
2,193,199

Operating income (loss)
22,873

 
(38,269
)
 
(200,451
)
 
 
 
(215,847
)
Interest and other income (expense), net
3,303

 
2,154

 

 
 
 
5,457

Interest expense
(5,763
)
 
(24,196
)
 
9,729

 
(E)
 
(20,230
)
Income (loss) before income taxes and noncontrolling interest
20,413

 
(60,311
)
 
(190,722
)
 
 
 
(230,620
)
Income tax provision (benefit)
(1,173
)
 
9,723

 

 
(C )
 
8,550

Equity in net loss equity method investees
(5,068
)
 

 

 
 
 
(5,068
)
Net income (loss)
16,518

 
(70,034
)
 
(190,722
)
 
 
 
(244,238
)
Adjust for net loss attributable to noncontrolling interests net of taxes
1,418

 

 

 
 
 
1,418

Net income (loss) attributable to Cypress Semiconductor Corporation
$
17,936

 
$
(70,034
)
 
$
(190,722
)
 
 
 
$
(242,820
)
 
 
 
 
 
 
 
 
 
 
Net income (loss) per share attributable to Cypress Semiconductor Corporation
 
 
 
 
 
 
 
 
 
   Basic
$
0.11

 
$
(1.15
)
 
 
 
 
 
$
(0.75
)
   Diluted
$
0.11

 
$
(1.15
)
 
 
 
 
 
$
(0.75
)
Cash dividend declared per share
$
0.44

 
$

 
 
 
 
 
$
0.44

Shares used in net income ( loss) per share calculation
 
 
 
 
 
 
 
 
 
   Basic
159,031

 
61,088

 
102,844

 
 (D)
 
322,963

   Diluted
169,122

 
61,088

 
102,844

 
 (D)
 
322,963

 
 
 
 
 
 
 
 
 
 
The accompanying notes are an integral part of these condensed consolidated financial statements










Notes to Unaudited Pro Forma Condensed Combined Financial Statements

1.
Basis of Presentation

On March 12, 2015, Cypress completed its merger with Spansion Inc., for consideration paid in Cypress shares, as described in the merger agreement. In addition, on the merger date, Cypress provided $150 million of cash to Spansion that Spansion used to repay its Senior Secured Term Loan on the merger date, which Cypress did not legally assume as part of the merger. For accounting purposes, the $150 million cash payment by Cypress to Spansion is considered as part of the total purchase price consideration. The merger is reflected in the unaudited pro forma condensed combined financial statements under the acquisition method in accordance with ASC 805, Business Combinations, with Cypress treated as the acquirer. Under the acquisition method, the total estimated purchase price allocation is calculated as described in Note 2. In accordance with ASC 805, the assets acquired and the liabilities assumed have been measured at fair value based on various preliminary estimates, and these estimates are subject to change pending further review of the fair value of assets acquired and liabilities assumed. The final amounts recorded for the merger may differ materially from the information presented herein.
The unaudited pro forma condensed combined financial statements were prepared in accordance with GAAP and pursuant to U.S. Securities and Exchange Commission Regulation S-X Article 11, and present the pro forma financial position and results of operations of the combined companies based upon the historical information after giving effect to the merger and adjustments described in these Notes to the Unaudited Pro Forma Condensed Combined Financial Statements. The unaudited pro forma condensed combined balance sheet is presented as if the merger had occurred on December 28, 2014, and the unaudited pro forma condensed combined statements of income for the year ended December 28, 2014 is presented as if the merger had occurred on December 30, 2013.
Cypress and Spansion have historically recorded a full valuation allowance on the majority of their deferred tax assets since it was more-likely-than not that such assets would not be realized. Following the merger, Cypress will need to assess whether a valuation allowance should be recorded on the deferred tax assets of the combined company, including those deferred tax assets that did not have an allowance in the accounts of Cypress before the merger. In accordance with the requirements of ASC 805, any change in the valuation allowance of Cypress would be reflected in the income tax provision in the reporting period that includes the merger.
Pursuant to the terms of severance agreements of certain named executive officers, Spansion provided cash severance and acceleration of unvested stock awards upon completion of the merger. The impact of these compensation charges has not been reflected in the unaudited pro forma condensed combined financial statements. However, these compensation charges will be recorded as merger related / restructuring expenses during the period subsequent to the merger.
Certain reclassifications adjustments have been made relative to Cypress’ and Spansion’s historical financial statements to conform to the financial statement presentation of Cypress and the combined company. Such reclassification adjustments are described in further detail in Note 4 to the unaudited pro forma condensed combined financial statements.
2. Total Purchase Price Consideration
Subject to the terms and conditions of the merger agreement, each outstanding share of Spansion common stock was converted into the right to receive 2.457 shares of common stock of Cypress.
The merger agreement further provides for each Spansion stock option and restricted stock award that is outstanding and unexercised at the closing date was assumed and converted into an option or award to purchase Cypress common stock based on the 2.457 conversion ratio. Based on Spansion’s stock options outstanding at March 12, 2015 and the 2.457 conversion ratio, the unaudited pro forma condensed combined financial statements present the conversion of Spansion options to purchase approximately 3.7 million shares of Spansion common stock into options to purchase approximately 9.0 million shares of Cypress common stock. In addition, the unaudited pro forma condensed consolidated financial statements also assume and convert approximately 1.8 million shares of outstanding Spansion restricted stock units (including performance-based awards) into approximately 4.4 million shares of Cypress restricted stock units (including performance-based awards), using the 2.457 conversion ratio. The estimated fair value of the stock options, the vested restricted stock units awards assumed and the restricted stock units earned

58



but unvested are converted based on closing price of Cypress stock as of March 12, 2015. Accordingly, the total purchase price consideration includes the fair value of the vested options to purchase approximately $89.7 million of Cypress common stock and the $68.8 million of Cypress vested restricted stock awards.
The fair value of the stock options assumed were determined using a Black-Scholes valuation model with market based assumptions. The fair value of restricted stock assumed is $15.68 per share, being the Cypress closing stock price on March 12, 2015. The fair value of earned, but unvested, restricted stock units relating to future services, and not yet earned, will be recorded as operating expenses over the remaining service periods. Option pricing models require the use of highly subjective market assumptions, including expected stock price volatility, which if changed can materially affect fair value estimates.
Based on the closing price of Cypress’ common stock on March 12, 2015, the total purchase price consideration was approximately $2.8 billion, including the fair value of vested Spansion stock awards assumed, and comprised of:

 
(in thousands, except exchange ratio and share price)
 
 
Number of Spansion shares outstanding
66,721

Multiplied by the conversion ratio
2.457

Number of common shares of Cypress issued to the holders of Spansion common stock
163,932

Multiplied by the price per Cypress ordinary share
$
15.68

Fair value of share consideration
$
2,570,458

Fair value of options assumed by Cypress
89,712

Fair value of earned but unvested Spansion stock awards as of merger date
8,026

Cash consideration for repayment of Spansion's Senior Secured Term Loan
150,000

Preliminary purchase price
$
2,818,196

For purposes of these unaudited pro forma condensed combined financial statements, the total purchase price consideration has been allocated among Spansion’s tangible and intangible assets and liabilities based on their estimated fair value as of December 28, 2014. The final allocation of the purchase price will be based on the fair value of such assets and liabilities as of March 12, 2015, the date of closing of the merger. Such final     determination of the purchase price allocation may be significantly different from the preliminary estimates used in these unaudited pro forma condensed combined financial statements.

3. Preliminary Estimated Purchase Price Allocation

Based upon a preliminary valuation, the total purchase price consideration of $2.8 billion was allocated to Spansion’s assets and liabilities as follows:


59



 
Fair Value
 
($ In thousands)
 Cash and cash equivalents
106,327

 Short term investments
50,588

 Accounts Receivable, net
136,863

 Inventories
399,591

 Other current assets
70,269

 Property, plant & equipment, net
442,952

 Goodwill
1,551,172

 Intangible assets, net
814,470

 Other long-term assets
57,642

      Total assets acquired
3,629,874

 Accounts Payable
(173,698
)
 Accrued compensation and benefits
(34,079
)
 Income tax payable
(1,361
)
 Other current liabilities
(178,543
)
 Deferred income tax
(5,343
)
 Other noncurrent liabilities
(41,404
)
 Long term debt (1)
(377,250
)
      Total liabilities assumed
(811,678
)
      Fair value of net assets acquired
2,818,196


(1) Includes the fair value of the debt and equity components of Spansion's 2.00% Senior Exchangeable Notes that were assumed by Cypress. The 2.00% Senior Exchangeable Notes have been assumed by Cypress post merger. See Note 4(i) for further details.

The final determination of the purchase price allocation will be based on the actual net tangible and intangible assets of Spansion that existed on March 12, 2015, the date of the merger and the completion of the valuation of the fair value of such net assets. Cypress anticipates that the ultimate purchase price allocation of balance sheet amounts such as current assets and liabilities (including inventory and the deferred margin on sales to distributors), property and equipment, intangible assets and long-term assets and liabilities will differ from the preliminary assessment outlined above. Any changes to the initial estimates of the fair value of the acquired assets and assumed liabilities will be recorded as adjustments to those assets and liabilities and residual amounts will be recorded as goodwill.

The unrecognized stock based compensation expense of $60.0 million associated with the portion of the assumed and converted stock options, and the restricted stock unit awards that are subject to future service requirements have not been included in above purchase price allocation and have not been included in the unaudited pro forma condensed combined financial statements. Cypress will record the unrecognized stock-based compensation expense within operating expenses over a weighted average amortization period of 2.9 years.

4. Preliminary Pro Forma Financial Statement Adjustments

Adjustments included in the column under the heading “Pro Forma Adjustments” represent the following:
Unaudited Pro Forma Condensed Combined Balance Sheet
Conforming Reclassification Adjustments Between Cypress and Spansion:
The following reclassification adjustments have been made in the presentation of Cypress’ historical financial statements to conform to the combined presentation. In addition, Cypress is in the process of reviewing Spansion’s accounting policies in order to conform to Cypress’ accounting policies.

$6.1 million reclassified from other current liabilities to current portion of long-term debt as of December 28, 2014.

60



$10.1 million reclassified from other long-term liabilities to long-term revolving debt facility and debt, non-current, as of December 28, 2014.

The following reclassification adjustments have been made in the presentation of Spansion’s historical financial statements to conform to the combined presentation:

$7.1 million reclassified from deferred income taxes to other current assets as of December 28, 2014.
$18.9 million reclassified from other long-term liabilities to deferred income taxes and other tax liabilities as of December 28, 2014.
Pro Forma Adjustments Relating to the Merger
(a)     Represents the additional borrowing by Cypress on its Senior Revolving Credit facility for $103.0 million to fund the repayment of Spansion's Senior Secured Term Loan.
(b)    Represents the repayment of Spansion's Senior Secured Term Loan balance of $293.7 million as of December 28, 2014. Spansion was required to pay off the Senior Secured Term Loan Facility in the event of a change in control. Spansion paid off the Senior Secured Term Loan using its own funds and the $150.0 million cash payment provided by Cypress on the merger date.

(c)    To record the difference in book value and fair value of inventory acquired in the merger. The amortization of the step up to the fair value of the inventory is recorded within cost of revenues in the unaudited pro forma condensed combined statement of operations for the year ended December 28, 2014 as the inventory is expected to be sold in less than one year.

(d)     To record the difference in book value and fair value of property, plant and equipment acquired in the merger. The step up in property, plant and equipment relates primarily to machinery and equipment and buildings, which have a current estimated weighted average useful life of two to eight years and will be depreciated on a straight-line basis. The amount of purchase price allocated to property, plant and equipment, as well as the associated useful lives, may increase or decrease and could materially affect the amount of depreciation expense to be recorded by Cypress in its future consolidated statements of operations.

(e)    Reflects the preliminary pro forma adjustment to goodwill, calculated as follows:

 
($ In thousands)
Total purchase price consideration
2,818,196

Less: Fair value of net assets acquired
(1,267,024
)
     Total estimated goodwill
1,551,172

Less: Spansion historical goodwill
(166,133
)
     Pro forma adjustment to goodwill
1,385,039

The goodwill to be recognized is primarily attributable to the assembled workforce, a reduction in costs and other synergies, and an increase in product development capabilities. The goodwill resulting from the merger is not expected to be deductible for tax purposes.

(f)    Reflects the preliminary estimates of the fair value of intangible assets acquired by Cypress as follows:


61



 
 
Estimated range
 
Historical
 
Estimated
 
Pro Forma
 
of Average Useful
Spansion
 
Fair Value
 
adjustments
 
Lives (in years)
(In thousands)
 
(In thousands)
 
(In thousands)
 
 
 
 
 
Developed technologies
 
5
 
$
66,419

 
$
481,500

 
$
415,081

Customer relationships
 
8
 
60,404

 
132,400

 
71,996

In process research and development
 
N/A
 
2,484

 
128,070

 
125,586

Tradenames and Trademarks
 
6
 

 
20,600

 
20,600

License agreements
 
 2 to 3
 
2,222

 
51,900

 
49,678

 
 
 
 
$
131,529

 
$
814,470

 
$
682,941

The preliminary estimates of fair value and useful life of the acquired intangible assets will likely be different from final fair values, and the difference could have a material impact on Cypress's future consolidated statements of operations.

Developed technologies acquired primarily consist of Spansion’s existing technologies related to embedded systems semiconductors which include flash memory, microcontroller, mixed-signal and analog products. An income approach was used to value Spansion’s developed technologies. Using this approach, the estimated fair value was calculated using expected future cash flows from specific products discounted to their net present values at an appropriate risk-adjusted rate of return. A discount rate of 8.5% was used to discount the cash flows to the present value.

Customer relationships represent the fair value of projected cash flows that will be derived from the sale of products to Spansion’s existing customers based on existing, in-process, and future versions of the existing technology. Customer relationships were valued utilizing a form of the income approach known as the “distributor” method since the primary income producing asset of the business was determined to be the technology assets. Under this premise, the margin a distributor earns is deemed to be the margin attributable to the Customer relationships. This isolates the cash flows attributable to the Customer relationships that a market participant would be willing to pay for.

In-process research and development, ("IPR&D"), represents the estimated fair values of incomplete Spansion research and development projects that had not reached technological feasibility as of the date of acquisition. In the future, the fair value of each project at the acquisition date will be either amortized or impaired depending on whether the projects are completed or abandoned. The “multi-period excess earnings” method was used to estimate the fair value of Spansion’s IPR&D. The acquisition date fair value of IPR&D will be either amortized or impaired depending on whether the projects are completed or abandoned.

Trade names and trademarks are considered a type of guarantee of a certain level of quality or performance represented by the Spansion brand. Trade names and trademarks were valued using the “relief-from-royalty income” approach. This method is based on the assumption that in lieu of ownership, a market participant would be willing to pay a royalty in order to exploit the related benefits of this asset. A discount rate of 10.0% was used to discount the cash flows to the present value.

License agreements represent the estimated fair value of Spansion’s existing license agreements under which Spansion generates revenue by licensing its intellectual property to third parties and assists its customers in developing and prototyping their designs by providing software and hardware development tools, drivers and simulation models for system-level integration. License agreements were valued using a form of the income approach known as the “multi-period excess earnings” approach. Under this approach, the expected cash flows associated with the license agreements were projected then discounted to present value at a rate of return that considers the relative risk of achieveing the cash flows and the time value of money. A discount rate of 8.0% was used to discount the cash flows to the present value.  


62




(g)    Reflects the pro forma adjustments to other current liabilities as follows:

 
Estimated transaction costs
Recorded in 2014 financial statements
Proforma adjustments
 
($ In thousands)
Transaction costs expected to be incurred by Spansion
$
37,540

$
4,140

$
33,400

Transaction costs expected to be incurred by Cypress
35,130

7,300

27,830

Pro forma adjustment to other current liabilities
$
72,670

$
11,440

$
61,230

Of the combined $61.2 million in estimated transaction costs, $45.6 million relates to investment banker fees and advisory fees. The remaining $15.6 million in estimated transaction costs primarily relate to professional fees associated with the merger, including legal, accounting, and tax, and regulatory filing and printing fees to be paid to third parties.

(h)    To record the elimination of Spansion's historical stockholders’ equity and to record the Cypress common stock issued for the merger consideration.

 
(In thousands, except
 
per share amounts)
Spansion shares acquired
 
66,721

Fixed exchange ratio
 
2.457

Number of common shares of Cypress issued to the holders of Spansion common stock
 
163,932

Closing price of Cypress common stock on March 12, 2015
 
$
15.68

Equity Consideration
 
$
2,570,458

Add: Fair value of options assumed
 
89,712

Add: Fair value of earned but unvested Spansion stock awards as of merger date
 
$
8,026

Add: Cash provided from Cypress for Spansion's Senior Secured Term Loan repayment
 
$
150,000

Total purchase price
 
$
2,818,196

Less: Historical Spansion stockholders’ equity
 
(528,684
)
Less: Cash provided from Cypress for Spansion's Senior Secured Term Loan repayment
 
(150,000
)
Less: Transaction costs expected to be incurred by Cypress
 
(27,830
)
Add: Fair value of equity portion of long term debt
 
245,213

Pro forma adjustment to stockholders’ equity
 
$
2,356,895


(i)    To record the fair value of the debt and equity components of Spansion’s 2.00% Senior Exchangeable Notes.
 
 
Historical Carrying Value
 
Fair Value
 
 
(In thousands)
Long term revolving credit facility and debt non current portion
 
$
116,439

 
$
132,037

Equity component
 
33,561

 
245,213

Total Spansion debt
 
$
150,000

 
$
377,250


63



(j) To record Spansion's deferred margin on sales to distributors to estimated fair value as a legal performance obligation is not being assumed by Cypress with respect to product held by Spansion's distributors at the time of the merger.
(k)     Reflects the elimination of capitalized financing costs relating to the Spansion's Senior Secured Term Loan and incremental capitalized financing costs due to additional borrowings by Cypress on its Senior Revolving Credit facility.
Unaudited Pro Forma Condensed Combined Statement of Operations
Conforming Reclassification Adjustments Between Cypress and Spansion:
The following reclassification adjustments have been made to the presentation of Cypress’ historical financial statements to conform to the combined presentation:

$5.8 million of interest expense presented separately for the year ended December 28, 2014.
The following reclassification adjustments have been made to the presentation of Spansion’s historical financial statements to conform to the combined presentation:

Amortization of acquisition-related intangibles for Spansion includes $36.0 million of amortization of acquired developed technologies and other intangibles included in Spansion’s cost of revenues for the year ended December 28, 2014.
Pro Forma Adjustments Relating to the Merger of Cypress and Spansion:

(A)
Reflects pro forma adjustments to the amortization of acquisition-related intangibles assuming the preliminary estimates of the fair value and estimated weighted average lives of the assets as described in Note (f) as follows:

 
Year Ended
December 28, 2014
(In thousands)
Pro forma amortization of purchased intangibles
$
137,043

Less: Spansion historical amortization of purchased intangibles
35,974

Pro forma adjustment to amortization of purchased intangibles
$
101,069


(B) Reflects pro forma adjustments to depreciation of property, plant and equipment assuming preliminary estimates of fair value and estimated useful life of the assets as described in Note (d) as follows:


64



 
Year Ended
December 28, 2014
(In thousands)
Pro forma depreciation for property, plant and equipment
$
79,965

Less: Spansion historical depreciation
(58,009
)
Pro forma adjustment to property, plant and equipment
$
21,956

Representing:
 
Cost of revenues
$
28,222

Research and development
$
(4,374
)
Selling, general and administrative
$
(1,892
)
(C) Due to valuation allowances on the net deferred tax assets for both Cypress and Spansion, the unaudited pro forma condensed combined consolidated statements of operations does not reflect statutory rate tax adjustments for pro forma purposes.
(D) To eliminate the historical outstanding basic shares of Spansion and reflect the new shares issued in connection with the merger of 163.9 million as shown below in Note 5.
(E) Reflects the elimination of interest on Spansion's Senior Secured Term Loan and the incremental interest expense relating to additional borrowing by Cypress on its Senior Revolving Credit facility.
5. Pro Forma Combined Net Loss per Share
The pro forma basic and diluted net loss per share presented in the unaudited pro forma condensed combined statement of operations is computed based on the pro forma weighted-average number of shares outstanding.

 
Year Ended
 
December 28, 2014
 
(In thousands)
Pro forma net loss attributable to Cypress Semiconductor Corporation, basic and diluted as combined
$
(242,820
)
Cypress's historical weighted average shares
159,031

Shares issued in connection with the merger as if they were issued on December 30, 2013 (1)
163,932

Pro forma weighted average shares outstanding, basic and diluted
322,963

 
 
Pro forma net loss per share:
 
Basic
$
0.75

Diluted
$
0.75


 
 
(In thousands, except per share data)
(1)
Spansion shares eligible for merger consideration
64,935

 
Spansion restricted stock units vested
1,786

 
Spansion shares acquired
66,721

 
Fixed exchange ratio
2.457

 
Spansion shares converted into Cypress common stock
163,932



65